Please assess the completion status of the following clinical trial:

Trial Title: Proton Pump Inhibitor Therapy and Bone Density in Premature Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Infants born between 24 and 34 weeks gestation and 600g to 2000g birth weight Parental consent has been obtained~Exclusion Criteria:~* Infants with bone disorders, liver or kidney problems, infants of diabetics, growth retarded infants, or infants taking diuretics or chronic steroids will be excluded.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PPI group (Type: None): This group of infants have received treatment with a PPI as ordered by their neonatologist during their hospital stay.
- non-PPI group (Type: None): These infants did not receive PPIs during their hospital stay.

Based on this trial design, predict the completion outcome and termination type (if applicable).